Pubblicazioni

Comparison between azacitidine and decitabine as front-line therapy in elderly acute myeloid leukemia patients not eligible for intensive chemotherapy

2023 - LEUKEMIA RESEARCH

Maurillo, L.; Spagnoli, A.; Candoni, A.; Papayannidis, C.; Borlenghi, E.; Lazzarotto, D.; Fianchi, L.; SciumÃ¨, M.; Zannier, M. E.; Buccisano, F.; Del Principe, M. I.; Mancini, V.; Breccia, M.; Fanin, R.; Todisco, E.; Lunghi, M.; Palmieri, R.; Fracchiolla, N.; Musto, P.; Rossi, G.; Venditti, A.

Azacitidine to Consolidate and Deepen the Therapeutic Response Achieved by Intensive Induction Treatment in a Young Patient Affected by NPM1mut-AML Who Has Become Ineligible for High-Dose Consolidation

2022 - CHEMOTHERAPY

Cenfra, Natalia; Lapietra, Gianfranco; Perrone, Salvatore; Voso, Maria Teresa; Divona, Mariadomenica; Mecarocci, Sergio; La Barbera, Elettra Ortu; Cimino, Giuseppe

Predictive factors for response and survival in elderly acute myeloid leukemia patients treated with hypomethylating agents: a real-life experience

2020 - ANNALS OF HEMATOLOGY

Pepe, S.; Scalzulli, E.; Colafigli, G.; Di Prima, A.; Diverio, D.; Mancini, M.; Latagliata, R.; Martelli, M.; Foa, R.; Breccia, M.

Comparative analysis of azacitidine and intensive chemotherapy as front-line treatment of elderly patients with acute myeloid leukemia

2018 - ANNALS OF HEMATOLOGY

Maurillo, Luca; Buccisano, Francesco; Spagnoli, Alessandra; Voso, Maria Teresa; Fianchi, Luana; Papayannidis, Cristina; Gaidano, Gian Luca; Breccia, Massimo; Musto, Pellegrino; de Bellis, Eleonora; Del Principe, Maria Ilaria; Lunghi, Monia; Lessi, Federica; Martinelli, Giovanni; Venditti, Adriano